322 related articles for article (PubMed ID: 38491477)
1. O-GlcNAcylation: a pro-survival response to acute stress in the cardiovascular and central nervous systems.
Xue Q; Ji S; Xu H; Yu S
Eur J Med Res; 2024 Mar; 29(1):174. PubMed ID: 38491477
[TBL] [Abstract][Full Text] [Related]
2. Hexosamine biosynthetic pathway promotes the antiviral activity of SAMHD1 by enhancing O-GlcNAc transferase-mediated protein O-GlcNAcylation.
Hu J; Gao Q; Yang Y; Xia J; Zhang W; Chen Y; Zhou Z; Chang L; Hu Y; Zhou H; Liang L; Li X; Long Q; Wang K; Huang A; Tang N
Theranostics; 2021; 11(2):805-823. PubMed ID: 33391506
[No Abstract] [Full Text] [Related]
3. New insights: A role for O-GlcNAcylation in diabetic complications.
Peterson SB; Hart GW
Crit Rev Biochem Mol Biol; 2016; 51(3):150-61. PubMed ID: 26806492
[TBL] [Abstract][Full Text] [Related]
4. First characterization of glucose flux through the hexosamine biosynthesis pathway (HBP) in
Olson AK; Bouchard B; Zhu WZ; Chatham JC; Des Rosiers C
J Biol Chem; 2020 Feb; 295(7):2018-2033. PubMed ID: 31915250
[TBL] [Abstract][Full Text] [Related]
5. Regulation of protein O-GlcNAcylation by circadian, metabolic, and cellular signals.
Liu X; Cai YD; Chiu JC
J Biol Chem; 2024 Feb; 300(2):105616. PubMed ID: 38159854
[TBL] [Abstract][Full Text] [Related]
6. Epithelial Mesenchymal Transition Induces Aberrant Glycosylation through Hexosamine Biosynthetic Pathway Activation.
Lucena MC; Carvalho-Cruz P; Donadio JL; Oliveira IA; de Queiroz RM; Marinho-Carvalho MM; Sola-Penna M; de Paula IF; Gondim KC; McComb ME; Costello CE; Whelan SA; Todeschini AR; Dias WB
J Biol Chem; 2016 Jun; 291(25):12917-29. PubMed ID: 27129262
[TBL] [Abstract][Full Text] [Related]
7. Targeting Protein
Bolanle IO; Palmer TM
Cells; 2022 Feb; 11(4):. PubMed ID: 35203353
[TBL] [Abstract][Full Text] [Related]
8. Foetal recapitulation of nutrient surplus signalling by O-GlcNAcylation and the failing heart.
Packer M
Eur J Heart Fail; 2023 Aug; 25(8):1199-1212. PubMed ID: 37434410
[TBL] [Abstract][Full Text] [Related]
9. O-GlcNAc signaling in the cardiovascular system.
Ngoh GA; Facundo HT; Zafir A; Jones SP
Circ Res; 2010 Jul; 107(2):171-85. PubMed ID: 20651294
[TBL] [Abstract][Full Text] [Related]
10. Protein O-GlcNAcylation: a new signaling paradigm for the cardiovascular system.
Laczy B; Hill BG; Wang K; Paterson AJ; White CR; Xing D; Chen YF; Darley-Usmar V; Oparil S; Chatham JC
Am J Physiol Heart Circ Physiol; 2009 Jan; 296(1):H13-28. PubMed ID: 19028792
[TBL] [Abstract][Full Text] [Related]
11. The Hexosamine Biosynthesis Pathway: Regulation and Function.
Paneque A; Fortus H; Zheng J; Werlen G; Jacinto E
Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107691
[TBL] [Abstract][Full Text] [Related]
12. O-GlcNAc elevation through activation of the hexosamine biosynthetic pathway enhances cancer cell chemoresistance.
Liu Y; Cao Y; Pan X; Shi M; Wu Q; Huang T; Jiang H; Li W; Zhang J
Cell Death Dis; 2018 May; 9(5):485. PubMed ID: 29706631
[TBL] [Abstract][Full Text] [Related]
13. Enzymatic assay for UDP-GlcNAc and its application in the parallel assessment of substrate availability and protein O-GlcNAcylation.
Sunden M; Upadhyay D; Banerjee R; Sipari N; Fellman V; Kallijärvi J; Purhonen J
Cell Rep Methods; 2023 Jul; 3(7):100518. PubMed ID: 37533645
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of
Xu H; Du M; Shen Y; Yang Y; Ding F; Yu S
Molecules; 2021 Sep; 26(19):. PubMed ID: 34641427
[No Abstract] [Full Text] [Related]
15. O-GlcNAc and the cardiovascular system.
Dassanayaka S; Jones SP
Pharmacol Ther; 2014 Apr; 142(1):62-71. PubMed ID: 24287310
[TBL] [Abstract][Full Text] [Related]
16. Role of the O-GlcNAc modification on insulin resistance and endoplasmic reticulum stress in 3T3-L1 cells.
Sermikli BP; Aydogdu G; Yilmaz E
Mol Biol Rep; 2020 Aug; 47(8):5927-5942. PubMed ID: 32691273
[TBL] [Abstract][Full Text] [Related]
17. Insights into the role of maladaptive hexosamine biosynthesis and O-GlcNAcylation in development of diabetic cardiac complications.
Qin CX; Sleaby R; Davidoff AJ; Bell JR; De Blasio MJ; Delbridge LM; Chatham JC; Ritchie RH
Pharmacol Res; 2017 Feb; 116():45-56. PubMed ID: 27988387
[TBL] [Abstract][Full Text] [Related]
18. O-GlcNAcylation, a sweet link to the pathology of diseases.
Nie H; Yi W
J Zhejiang Univ Sci B; 2019 May; 20(5):437-448. PubMed ID: 31090269
[TBL] [Abstract][Full Text] [Related]
19. Acute regulation of cardiac metabolism by the hexosamine biosynthesis pathway and protein O-GlcNAcylation.
Laczy B; Fülöp N; Onay-Besikci A; Des Rosiers C; Chatham JC
PLoS One; 2011 Apr; 6(4):e18417. PubMed ID: 21494549
[TBL] [Abstract][Full Text] [Related]
20. Aberrant O-GlcNAcylated Proteins: New Perspectives in Breast and Colorectal Cancer.
Chaiyawat P; Netsirisawan P; Svasti J; Champattanachai V
Front Endocrinol (Lausanne); 2014; 5():193. PubMed ID: 25426101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]